The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Healthcare in the U.S. – The New Normal

Following the release of the new U.S. bioeconomy strategy, and as we head toward this year’s BIO Convention in Boston, Deloitte is presenting a webcast that may be of interest on how the U.S. healthcare system will deal with an aging population and increasing cost pressures:

Health Sciences Consolidation: Industry’s Response to the New Normal 

The webcast will discuss factors driving the future of consolidation in the following sectors:

  1. Biotech and Pharmaceutical Manufacturers
  2. Hospitals
  3. Commercial Health Insurance

Click here to register for the webcast.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 130 other followers

%d bloggers like this: